Alterations of hepatic lipid content following COVID-19 in persons with type 2 diabetes.

ABSTRACT:

Introduction

The study aimed to assess the effect of COVID-19 on hepatic lipid (HL) content, fibrosis risk, and adiposity in persons with type 2 diabetes.

Research design and methods

Participants with type 2 diabetes with a history of mild COVID-19 (n=15, age 58±12 years, body mass index 30.9±5.2 kg/m²) were examined before (baseline) and 1 year (12±2 months) after (follow-up) recovery from COVID-19. Investigations for changes in metabolic risk comprised clinical examination, fasting blood sampling and MR-based measurements. Potential changes were corrected with the time course of the respective parameters in a group of participants who did not contract COVID-19 over the same time course (n=14, 61±6 years, 30.0±4.6 kg/m²).

Results

COVID-19 result

SUBMITTER: Kupriyanova Y 

PROVIDER: S-EPMC11836859 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature